The Latin America, Middle East and Africa Thoracic Surgery Devices Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030).
Robotic-assisted surgery is gaining prominence, offering precision and dexterity beyond the capabilities of traditional surgery. The da Vinci Surgical System, among others, has revolutionized the field of thoracic surgery. Surgeons are increasingly using robotic systems to perform complex procedures with greater precision. Thoracic surgery devices incorporate advanced imaging technologies like 3D CT scans and intraoperative imaging. These tools provide surgeons with real-time, high-resolution images, enhancing their ability to navigate complex anatomical structures during surgery.
These techniques require specialized devices and instruments designed for precision and efficacy, propelling innovation, and market growth. Access to healthcare services, such as thoracic surgeries, is increasing demand for thoracic surgery devices. As more healthcare facilities offer thoracic surgical procedures, there is a commensurate rise in the need for devices that aid in diagnosis, treatment, and postoperative care, accelerating market expansion.
According to the National Library of Medicine, in the Middle East, the prevalence of CVD is high (10.1%). Minimally invasive surgical techniques for cardiac procedures are gaining popularity in the Middle East. The growing prevalence of cardiovascular diseases in the Middle East substantially impacts the market in the region. In Saudi Arabia, surgical resections, such as lobectomy and pneumonectomy, are commonly performed to treat lung cancer. Lung cancer is a growing health issue in Saudi Arabia, affecting a substantial portion of the population. Expanding healthcare access and increasing health insurance coverage for patients with lung cancer are priorities in Saudi Arabia. As more individuals access healthcare services, the demand for thoracic surgery procedures and associated devices increases in Saudi. As per the Saudi Arabia Ministry of Health, lung cancer is the fifth most prevalent cancer in Saudi Arabian men and the fifteenth most prevalent disease in Saudi women. Thoracic surgery devices are vital in addressing these cases and ensuring access to life-saving procedures. All these factors will uplift the regional market expansion in the coming years.
The Brazil market dominated the LAMEA Thoracic Surgery Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $19.5 Million by 2030. The Argentina market is showcasing a CAGR of 8.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.4% during (2023 - 2030).
Based on Surgery Type, the market is segmented into Lobectomy, Wedge Resection, Pneumonectomy, and Others. Based on Product, the market is segmented into Forceps, Graspers, Clamps & Staplers, Scissors, Spreaders, Needle Holders, and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Thoracic Surgery Devices Market is Projected to reach USD 998.1 Million by 2030, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Cardiotrack, Intuitive Surgical, Inc., Richard Wolf GmbH, Grena Ltd., Dextera Surgical Inc. (Aesculap Inc.), Teleflex, Inc., Medela AG, LivaNova PLC, and Sklar Corporation.
By Surgery Type
By Product
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
